FDA Inspection 985214 — Novo Nordisk A/S - Hax
The FDA completed an inspection of Novo Nordisk A/S - Hax on Jun 14, 2016 in Gentofte. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 14, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gentofte (Denmark)